Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00828
Species: Homo sapiens
Position : chr20:44478646-44484559
Year: 2011
Title: Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  21556051
MONDO: MONDO:0008315
Tissue: prostate gland
Tissue Ontology ID: UBERON:0002367
Cell Source: PC-3
CVCL ID: CVCL_0035
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay; Chromatin interaction assay; Disease-associated enhancer analysis
Low Throughput Method: Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP; 3C; Western blot
About Target Gene
Target gene : UBE2C
About TF
TF name : GATA2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
GATA2 AP-1 transcription factor network pid 71
GATA2 Factors involved in megakaryocyte development and platelet production reactome 111
GATA2 HIF-1-alpha transcription factor network pid 67
GATA2 IL3 netpath 84
GATA2 Regulation of Androgen receptor activity pid 54
GATA2 Signaling events mediated by HDAC Class I pid 89
GATA2 Signaling events mediated by HDAC Class II pid 58
GATA2 Hs_Apoptosis_WP254_88977 wikipathways 31
Enhancer Associated Network
Overlapping Enhancers (hg19) 7 found
Enhancer ID Position Tissue Cell Disease
E_00823 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00824 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00825 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00826 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00827 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00829 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00830 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
Expression of Target Genes for the Enhancer